Therakind
Simple reusable intranasal device designed to actively deliver medicine in order to reduce anxiety in patients/care-givers and increase treatment adherence
- Funding £100,000
- Competition Medicines Adherence
- Competition Date Spring 2014
- Local AHSN Imperial College Health Partners AHSN
- Website https://www.therakind.com/
- Key Contact Louise Rawcliffe
- Status In Development
- Pathways Medicines Adherence
-
Technology Medical Devices
Extending the applicability of Therakind’s previously developed single use intranasal dry powder parenteral administration system for use with a wider range of drugs. The newly extended role of the device is to utilise the same underlying technology in a reusable form to allow its application to more regularly used medication.
Comments are closed.